{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "da81a045",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from typing import Dict, List\n",
    "from transformers import AutoTokenizer\n",
    "from tqdm import tqdm\n",
    "import scml\n",
    "from scml import nlp as snlp\n",
    "import mylib"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "8cd61302",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option(\"use_inf_as_na\", True)\n",
    "pd.set_option(\"max_info_columns\", 9999)\n",
    "pd.set_option(\"display.max_columns\", 9999)\n",
    "pd.set_option(\"display.max_rows\", 9999)\n",
    "pd.set_option('max_colwidth', 9999)\n",
    "tqdm.pandas()\n",
    "scml.seed_everything()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "b202f64f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "PreTrainedTokenizerFast(name_or_path='pretrained/google/electra-small-discriminator', vocab_size=30522, model_max_len=512, is_fast=True, padding_side='right', special_tokens={'unk_token': '[UNK]', 'sep_token': '[SEP]', 'pad_token': '[PAD]', 'cls_token': '[CLS]', 'mask_token': '[MASK]'})\n",
      "['input_ids', 'token_type_ids', 'attention_mask']\n"
     ]
    }
   ],
   "source": [
    "pretrained_dir = \"pretrained/google/electra-small-discriminator\"\n",
    "model_max_length = 512\n",
    "tokenizer = AutoTokenizer.from_pretrained(pretrained_dir, model_max_length=model_max_length)\n",
    "print(f\"{repr(tokenizer)}\\n{tokenizer.model_input_names}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "df246981",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 19661 entries, 0 to 19660\n",
      "Data columns (total 5 columns):\n",
      " #   Column         Non-Null Count  Dtype \n",
      "---  ------         --------------  ----- \n",
      " 0   Id             19661 non-null  object\n",
      " 1   pub_title      19661 non-null  object\n",
      " 2   dataset_title  19661 non-null  object\n",
      " 3   dataset_label  19661 non-null  object\n",
      " 4   cleaned_label  19661 non-null  object\n",
      "dtypes: object(5)\n",
      "memory usage: 768.1+ KB\n"
     ]
    }
   ],
   "source": [
    "train = pd.read_csv(\"input/train.csv\", engine=\"c\", low_memory=False)\n",
    "train.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "ffdb0cfc",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "19661it [00:00, 330459.60it/s]\n"
     ]
    }
   ],
   "source": [
    "gt_map: Dict[str, List[str]] = {}\n",
    "dl_map: Dict[str, List[str]] = {}\n",
    "for t in tqdm(train.itertuples()):\n",
    "    pid = getattr(t, \"Id\")\n",
    "    cl = getattr(t, \"cleaned_label\")\n",
    "    dl = getattr(t, \"dataset_label\")\n",
    "    if pid not in gt_map:\n",
    "        gt_map[pid] = list()\n",
    "    if pid not in dl_map:\n",
    "        dl_map[pid] = list()\n",
    "    gt_map[pid].append(cl)\n",
    "    dl_map[pid].append(dl)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "d546c749",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  2%|▏         | 317/14316 [00:00<00:38, 360.72it/s]Token indices sequence length is longer than the specified maximum sequence length for this model (594 > 512). Running this sequence through the model will result in indexing errors\n",
      "100%|██████████| 14316/14316 [00:51<00:00, 279.08it/s]\n"
     ]
    }
   ],
   "source": [
    "rows = []\n",
    "sep = \"|\"\n",
    "m = 650\n",
    "negative_examples = 3\n",
    "max_length = 500\n",
    "for rid, gts in tqdm(gt_map.items()):\n",
    "    is_multi = 0\n",
    "    if len(gts) > 1:\n",
    "        is_multi = 1\n",
    "    ground_truth = sep.join(sorted(gts))\n",
    "    dataset_labels = sep.join(sorted(dl_map[rid]))\n",
    "    with open(f\"input/train/{rid}.json\") as in_file:\n",
    "        sections = json.load(in_file)\n",
    "    tmp = []\n",
    "    for section in sections:\n",
    "        tmp.append(section[\"text\"])\n",
    "    text = \" \".join(tmp).strip()\n",
    "    text = snlp.to_ascii_str(text)\n",
    "    spans = []\n",
    "    for dl in dl_map[rid]:\n",
    "        i = 0\n",
    "        j = len(text)\n",
    "        while i < j - len(dl) + 1:\n",
    "            a = text.find(dl, i, j)\n",
    "            if a == -1:\n",
    "                break\n",
    "            b = a + len(dl)\n",
    "            spans.append((a, b))\n",
    "            i = b\n",
    "            # Right context: answer is on the left edge of window\n",
    "            b = 2 * m + a\n",
    "            _len = len(tokenizer(text[a:b])[\"input_ids\"])\n",
    "            while _len > max_length and a < b:\n",
    "                b -= 100\n",
    "                _len = len(tokenizer(text[a:b])[\"input_ids\"])\n",
    "            row = {}\n",
    "            row[\"Id\"] = rid\n",
    "            row[\"is_multi\"] = is_multi\n",
    "            row[\"ground_truth\"] = ground_truth\n",
    "            row[\"dataset_labels\"] = dataset_labels\n",
    "            row[\"is_impossible\"] = 0\n",
    "            row[\"answer_start\"] = 0\n",
    "            row[\"answer_end\"] = len(dl)\n",
    "            row[\"context\"] = text[a:b]\n",
    "            row[\"context_token_length\"] = _len\n",
    "            rows.append(row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "d0cd8a73",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 61002 entries, 0 to 61001\n",
      "Data columns (total 9 columns):\n",
      " #   Column                Non-Null Count  Dtype \n",
      "---  ------                --------------  ----- \n",
      " 0   Id                    61002 non-null  object\n",
      " 1   is_multi              61002 non-null  int8  \n",
      " 2   ground_truth          61002 non-null  object\n",
      " 3   dataset_labels        61002 non-null  object\n",
      " 4   is_impossible         61002 non-null  int8  \n",
      " 5   answer_start          61002 non-null  int8  \n",
      " 6   answer_end            61002 non-null  int8  \n",
      " 7   context               61002 non-null  object\n",
      " 8   context_token_length  61002 non-null  int8  \n",
      "dtypes: int8(5), object(4)\n",
      "memory usage: 2.2+ MB\n"
     ]
    }
   ],
   "source": [
    "df = pd.DataFrame.from_records(rows)\n",
    "#df = pd.DataFrame(tmp, columns=[\"Id\", \"is_multi\", \"ground_truth\", \"dataset_labels\"])\n",
    "cols = [\"is_multi\", \"is_impossible\"]\n",
    "df[cols] = df[cols].astype(np.int8)\n",
    "cols = [\"answer_start\", \"answer_end\", \"context_token_length\"]\n",
    "df[cols] = df[cols].astype(np.int8) \n",
    "df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "c5eb4476",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Id</th>\n",
       "      <th>is_multi</th>\n",
       "      <th>ground_truth</th>\n",
       "      <th>dataset_labels</th>\n",
       "      <th>is_impossible</th>\n",
       "      <th>answer_start</th>\n",
       "      <th>answer_end</th>\n",
       "      <th>context</th>\n",
       "      <th>context_token_length</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>27897</th>\n",
       "      <td>50360796-e02b-49e1-8de8-4f9c01f715f2</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI subjects (mean ages  80 years 11 months vs. 75 years 5 months). Fourth, the ADNI MCI sample was restricted to the AD prodrome, a-MCI, and the AD sample was restricted to probable AD. The Wechsler logical memory test was used to distinguish a-MCI subjects from other MCI subjects during initial testing: Subjects were required to have scores in the 2-8 range on the delayed part of this test (the maximum score is 25) to be included in the MCI sample. As a result, although ADAMS MCIs were a mixture of a-MCI and n-MCI, ADNI MCIs were exclusively a-MCI. This is important when it comes to testing theoretical hypotheses about the retrieval processes that differentiate HC, MCI, and AD groups and that predict future HC  MCI and MCI  AD transitions. Those processes might be different when the MCI group is restricted to subjects with significant memory impairment and when the AD group is restricted to probable AD.\\nAs mentioned, ADNI subjects were rediagnosed at regular intervals over the next 2 years. Nearly half the a-MCI subjects converted to AD, and the rest did not (designated as the a-MCI C and a-MCI NC subgroups below). A small proportion (8%) of the HC subjects converted to a-MCI, and the rest did not (designated as the HC C and HC NC subgroups below). Before detailed results are</td>\n",
       "      <td>55</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39706</th>\n",
       "      <td>7bba3169-50ae-4ac7-9c5a-b8dba5918149</td>\n",
       "      <td>0</td>\n",
       "      <td>adni</td>\n",
       "      <td>ADNI</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI study to ensure compatibility across scanners [28] . Full brain and skull coverage was required and detailed quality control was carried out on all MR images according to the AddNeuroMed quality control procedure [23, 29] . We applied the Freesurfer pipeline (version 4.5.0) to the MRI images to produce regional cortical thickness and subcortical volumetric measures. Cortical reconstruction and subcortical volumetric segmentation includes removal of non-brain tissue using a hybrid watershed/surface deformation procedure [30] , automated Talairach transformation, segmentation of the subcortical white matter and deep grey matter volumetric structures (including hippocampus, amygdala, caudate, putamen, ventricles) [30] [31] [32] , intensity normalization [33] , tessellation of the grey matter white matter boundary, automated topology correction [34, 35] , and surface deformation following intensity gradients to optimally place the grey/white and grey/cerebrospinal fluid borders at the location where the greatest shift in intensity defines the transition to the other tissue class [36] [37] [38] . Once the cortical models are complete, registration to a spherical atlas takes place which utilizes individual cortical folding patterns to match cortical geometry across subjects [39] .</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11450</th>\n",
       "      <td>3f3033e9-4f55-4fd0-ac47-330be5a51791</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI, and also one of the most widely used test of dementia severity in NACC [30] .\\nDepression scores (Geriatric Depression Scale, GDS): These are scores from a screening test designed to identify depression symptoms in the elderly. A 15-item GDS bigger or equal to 6 was an exclusion criterion in ADNI. Individuals with history of major depression or bipolar disorder within the past year were also excluded from the study. In NACC, GDS is not recorded for individuals with severe dementia, but it is not used as an exclusion criterion for study entry. It should be noted, however, that GDS is not a required form in NACC, so it may not be recorded for any participant at any visit. Due to the inclusion/exclusion criteria and the reduced number of assessments of the GDS score in the datasets considered, the results and conclusions about the potential effect of depression should be interpreted with extra caution. Individuals were classified in three clinical states: CN, MCI and D. We focused on MCICN, DMCI and DCN as the possible back-transitions during disease development. In ADNI, there were no direct transitions from D back to CN. In NACC, 43 such transitions were observed. The possible transitions between the different states are as shown in the schematic diagram of Fig. 1 .\\nFor the a</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33971</th>\n",
       "      <td>07fde929-348c-4408-bdd7-15627aba6ae7</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI.\\nLessons from ADNI relevant to the PD initiative include the need to define the key scientific questions to be answered, standardize data collection protocols, build tools that are sophisticated and matched to the data collected, maintain open communication with the research community about their needs to predict future needs; and anticipate what informatics tools/resources will be needed to address new research questions. Several platforms and networks recently established or in development are positioned to address some of these issues:\\n The MRC Dementias Platform UK (DPUK) plans to bring together 22 cohorts from across the UK, including the UK Biobank, integrated into a single informatics platform. DPUK also plans to develop a readiness cohort with baseline imaging data as well as amyloid, genetics discovery, and -omics discovery cohorts. (EMIF) is a five-year IMI with 56 partners in 14 European countries, established to make datasets visible to researchers, to integrate research cohorts for combined analysis, and to enable re-use of medical and other data for research. IMI-EMIF is establishing three broad approaches to data reutilizing and sharing. Firstly, to make data visible and potentially utilizable by researchers, it has established a browser for meta-data or descr</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56198</th>\n",
       "      <td>165eaf2d-2a65-4b56-974b-6f2a9f42a390</td>\n",
       "      <td>0</td>\n",
       "      <td>early childhood longitudinal study</td>\n",
       "      <td>Early Childhood Longitudinal Study</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>34</td>\n",
       "      <td>Early Childhood Longitudinal Study in the U.S. found that children who were overweight when they entered kindergarten were 4 times more likely to be obese at age 14 than children who entered kindergarten at a healthy weight. 16 Once present, obesity is difficult to treat due to metabolic changes that resist weight loss. 17 Effective primary prevention efforts are needed early in life before physiologic barriers to weight loss take hold and less healthful weight-related behaviours become entrenched. The current study examines the efficacy of a primary obesity prevention intervention that embeds weight-related messages within a parenting program that has been shown to improve parenting behaviors among racial/ethnic minority families. 18 A formative pre-post uncontrolled trial with 16 families showed that we could feasibly implement the Parents and Tots Together intervention within a community setting and the intervention was acceptable to families. 6 The purpose of the current study was to assess the extent to which the Parents and Tots Together intervention, compared with controls who received weekly mailings, resulted in a smaller increase in BMI (primary outcome) and improvements in children's weight-related behaviors and parental feeding and general parenting behaviors among ra</td>\n",
       "      <td>-14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38055</th>\n",
       "      <td>3ba42bd7-4106-4470-b606-385f12b7566d</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI data set to support currently hypothetical models, but further to highlight uncertainty in those orderings and variation among different subgroups. We also demonstrate that such a model can provide a practical and effective staging system for patient prognosis.</td>\n",
       "      <td>49</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27323</th>\n",
       "      <td>50b0c82c-2a54-40be-990c-2a6cb033ba6c</td>\n",
       "      <td>0</td>\n",
       "      <td>adni</td>\n",
       "      <td>ADNI</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI was not designed to investigate the relationship between vascular disease and risk factors and cognitive decline, the variables making up the Vascular Index score were recorded as dichotomous values (present/ absent) and severity, duration, and timing of vascular risk factors were not accounted for. Therefore, there may have been underreporting or nonspecific reporting of vascular risk factors, which may have led to an underestimation of the effects of vascular risk factors on cognitive decline. The sample predominantly consisted of subjects with MCI, and therefore it is possible that this diagnostic group drove the results. However, the various models included interaction terms of vascular disease and risk factors with diagnostic group and those were not significant suggesting that diagnostic group did not modify the relationship between vascular disease and risk factors and cognitive impairment. Finally, due to our large sample, certain statistically significant results were not necessarily clinically relevant. Therefore, various designations of effect size were provided to better interpret the results.\\nIn conclusion, these results suggest that there is a significant association between increased vascular disease and risk factors and cognitive impairment in the AD spectrum</td>\n",
       "      <td>-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38467</th>\n",
       "      <td>b2769b41-6264-4457-acde-90aa25fea067</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI2/GO dataset (using T1w and FLAIR scans). Not using the T2w/PD information did not change the performance of the Random Forest classifier (SI=0.66  0.17, ICC=0.99). However, not using FLAIR information in the ADC dataset significantly decreased the Dice Kappa, but the volumetric correlation did not drastically change (SI=0.47  0.21, ICC=0.95). White matter hyperintensities (WMHs), commonly identified as areas of increased signal in relation with the surrounding white matter regions on T2w, PD and FLAIR MRIs, are one of the non-specific yet typical and constant MRI expressions of cerebral small vessel disease (CSVD), along with lacunar infarcts and microhemorrhages (Conklin et al., 2014; Gouw et al., 2010) . They have been shown to be more extensive in patients with Alzheimer's disease compared to agematched healthy normal populations (Yoshita et al., 2005) . WMHs reflect ischemic injury in the elderly and AD populations and the existence and severity of WMHs can lead to or accelerate decline in cognitive as well as executive functions (Dubois et al., 2014) . As a result, the location and load of WMHs are important clinical measures, raising substantial need for their accurate quantifications. WMHs are generally detected using fluid attenuated inversion recovery (FLAIR) or T2w</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31267</th>\n",
       "      <td>7e875ded-00ec-4570-8c5d-c39478bdf85d</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI1, ADNIGO, ADNI2, and AIBL datasets were downloaded from Alzheimer's disease Neuroimaging Initiative (ADNI) database (http://adni.loni.usc.edu/). The Australian Imaging, Biomarker &amp; Lifestyle (AIBL) Flagship Study of Ageing is a collaborative study that shares many common goals with ADNI (http://adni.loni.usc.edu/study-design/collaborative-studies/ aibl/). Only ADNI-compliant subjects with at least three timepoints from AIBL were included in this study. For all ADNI cohorts, subjects with clinical assessments from at least three visits, in timespan longer than one year, were included in the analysis. Subjects were further excluded based on manual quality checks after MR preprocessing pipelines (described below). Age, Apolipoprotein E4 (APOE4) status, clinical scores from mini-mental state exam (MMSE) and Alzheimer's Disease Assessment Scale (ADAS-13), and T1-weighted MR images were used in the analysis. Subject demographics are shown in Table 1 , and the complete list of included subjects is provided in S1 File.\\nThe ADNI sample comprising pooled ADNI1, ADNIGO, and ADNI2 subjects was used to perform primary analysis comprising trajectory modeling and prediction tasks, whereas AIBL subjects were used as the independent replication cohort for the prediction task. There are a few</td>\n",
       "      <td>64</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32199</th>\n",
       "      <td>54a8145c-6503-4fa7-9e77-ead6321bdf7d</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI were found to meet the above criteria and are thus included in the P-MCI group. For the other three clinical groups, subjects are selected to match the demographic information in the P-MCI group and to have the same gender and age. Specifically, for each subject in P-MCI group, a subject with the same gender and age is sought in the other group. If this is not possible, the gender constraint is relaxed first, and then the age constraint. However, under no circumstances are subjects with an age difference greater than 3 years included. Due to the similar reason for the calculation of dynamic features, the subjects in the other clinical groups are required to have at least 4 time-points. The demographic and clinical information of all the selected subjects in the four groups are summarized in Table 1 . The preprocessing step performed in our method is a standard procedure as used in general brain image analysis, aiming to reduce image noise and remove non-brain tissues. For each image, intensity inhomogeneity is firstly corrected using the N3 algorithm (Sled et al., 1998) . Many algorithms have been developed to remove non-brain tissues, such as the skull and the extra-cranial tissues, including Brain Surface Extractor (BSE) (Shattuck and Leahy, 2001 ) and Brain Extraction Too</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47255</th>\n",
       "      <td>6fa563ab-1ced-40a3-a626-103306098092</td>\n",
       "      <td>1</td>\n",
       "      <td>beginning postsecondary student|beginning postsecondary students|beginning postsecondary students longitudinal study</td>\n",
       "      <td>Beginning Postsecondary Student|Beginning Postsecondary Students|Beginning Postsecondary Students Longitudinal Study</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>31</td>\n",
       "      <td>Beginning Postsecondary Students: Two Years Later (Washington, D.C.:1994). Appendix A contains a detailed description of the persistence and attainment variables used in this report. degree, or a vocational certificate. This perspective is useful when the level of the degree that the students are seeking is not the highest undergraduate degree offered at the institution that they are attending at the time. This is especially common at community colleges, where students May be taking courses toward either a bachelor's degree or a vocational certificate rather than an associate's degree. The fourth approach presented in this essay is to focus specifically on the students with a bachelor's degree objective who are beginning at 4-year institutions and to trace their progress towards the bachelor's degree on a year-by-year basis. This perspective is useful in determining what proportion of beginning students at 4-year colleges follow a path of continuous enrollment towards the bachelor's degree and how long it takes them to achieve their objective. One of the most important distinctions in studying persistence and attainment is the highest undergraduate degree offered at the institution in which the student enrolls, because the time spent at the institution reflects the normal duratio</td>\n",
       "      <td>-13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7579</th>\n",
       "      <td>6348404c-81b2-4bb2-8a55-6a8f9880725f</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI-GO and ADNI-2 will follow 3 cohorts of subjects.\\n(1) Cognitively normal and late MCI subjects carried forward from ADNI-1 (followed at 1.5T); (2) early MCI enrolled in GO and carried forward into ADNI-2 (scanned at 3T); and (3) cognitively normal, late MCI, and Alzheimer's disease (AD) subjects newly enrolled in ADNI-2 (scanned at 3T).\\nNext, we describe the rationale that led to the selection of the MRI protocol for ADNI-GO and ADNI-2. Our approach to the ADNI-GO and ADNI-2 MRI protocol will be to maintain MRI methodological consistency to the greatest extent possible in previously enrolled ADNI-1 subjects, and to maximize the value of the longitudinal MRI data in these subjects. However, for newly enrolled subjects in GO (and ADNI-2 if funded), we will modernize and expand the MRI protocol to remain technically current, within the constraints imposed by having to operate in a reasonably consistent manner across many individual scanner models representing the three largest MRI vendors. Given the sensitivity of MRI as a biological marker demonstrated in ADNI-1, ADNI-GO and ADNI-2 are designed to further assess usefulness among individuals who are cognitively normal or have even more subtle cognitive impairment. This approach will serve to address two important objectives: how</td>\n",
       "      <td>43</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28946</th>\n",
       "      <td>c3e7b7fc-ea29-43af-8559-98f323d1007d</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI) database (www.loni.ucla.edu/ADNI). The ADNI was launched in 2003 by the National Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration (FDA), private pharmaceutical companies and non-profit organizations, as a $60 million, 5-year public-private partnership. The primary goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). Determination of sensitive and specific markers of very early AD progression is intended to aid researchers and clinicians to develop new treatments and monitor their effectiveness, as well as lessen the time and cost of clinical trials.\\nThe Principle Investigator of this initiative is Michael W. Weiner, M.D., VA Medical Center and University of California, San Francisco. ADNI is the result of efforts of many coinvestigators from a broad range of academic institutions and private corporations, and subjects have been recruited from over 50 sites across the U.S. and Canada. The initial goal of ADNI was to recruit 800 adults, ages 55 to 90</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52167</th>\n",
       "      <td>a35ecb88-abc8-4626-b411-2e70a67893b4</td>\n",
       "      <td>0</td>\n",
       "      <td>early childhood longitudinal study</td>\n",
       "      <td>Early Childhood Longitudinal Study</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>34</td>\n",
       "      <td>Early Childhood Longitudinal Study project (ECLS) provides decisionmakers, researchers, child care providers, teachers, and parents with detailed information about children's early life experiences through two cohorts, the Birth Cohort (ECLS-B) and the Kindergarten Cohort (ECLS-K). The ECLS-B, the focus of this report, is a large scale nationally representative probability sample of children born in 2001 selected from a multistage sample design. The sample size for the base year data collection, which occurred when children were approximately 9 months of age, was 13,921. The overall response rate (10,688 parent completes) was 74.1 percent. Details on the sample design, sample selection, and data collection can be found in the ECLS-B Methodology Report for the Nine-Month Data Collection, Volume 2: Sampling (NCES 2005-113), available from NCES at http://nces.ed.gov/ecls.  The ECLS-B is a rich data set that obtains information about a broad range of children's early experiences. Data collection is intended to continue through the end of first grade with the subsequent data collections at 2 years, 4 years, kindergarten, and the final data collection during first grade. This report documents the methodology for the child assessments in the ECLS-B, including the design, construction, i</td>\n",
       "      <td>31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60944</th>\n",
       "      <td>a1d94284-c438-4d0c-a8dd-f1bf65a70291</td>\n",
       "      <td>0</td>\n",
       "      <td>genome sequences of covid 19</td>\n",
       "      <td>genome sequences of COVID-19</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>28</td>\n",
       "      <td>genome sequences of COVID-19 and of Ebola [26] .\\nInterestingly, a study of isolated phospholipid monolayers [27] without any viral environment and with various degrees of unsaturation has shown similar kinetic behavior to that for SARS. The degradation with time of different phospholipid molecules exposed to laboratory air was monitored. Remembering the discussion above about the effect of the proximity of double bonds in the lipid structure to the sites for hydrogen atom removal, it is interesting to see that a lipid with one double bond had a longer degradation t 1/2 of 6120 s than the t 1/2 of 5040 s for a lipid with two double bonds. Some caution is needed, though, in making comparisons of t 1/2 values. For example, the phospholipids were, as mentioned, exposed to laboratory air and hence to ambient lighting conditions, and, as we have already indicated and as we shall see further below, light can enhance the reaction kinetics. Then, as will also be discussed below, rates of lipid oxidation can vary depending on their physical state. For the phospholipid studies, monolayers were spread on a pure water surface of a Langmuir trough. Surface oxidations are generally slower than for aerosol samples so that may be why the rates of oxidation of simple molecules appear to be less ra</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23137</th>\n",
       "      <td>689b095a-a58a-4300-a06d-0c1f222c8a80</td>\n",
       "      <td>0</td>\n",
       "      <td>adni</td>\n",
       "      <td>ADNI</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI participants, acquired from Siemens, general electric (GE), Philips, Siemens HRRT and BioGraph HiRez PET scanners, were collected from the ADNI Laboratory on NeuroImaging (LONI, University of California, Los Angeles) website (http://www.loni.ucla.edu/ADNI/). Participant's enrolment was conditioned to some eligibility criteria. General inclusion/exclusion criteria were as follows:\\n Normal control subjects: MMSE scores between 24 and 30 (inclusive), a CDR of 0, non-depressed, nonMCI, and nondemented. The age range of normal subjects will be roughly matched to that of MCI and AD subjects. For posterior analysis, the data was arranged into only one group, considering the case AD vs CTRL. This group has n = 196 images in total: 101 CTRL and 95 AD. We will consider that each spatially and intensity normalized image from the database corresponds to a different observation of the brain. The complexity of brain structures and the differences between brains of different subjects makes difficult to use the registered images for all type of calculations that directly compares them with each other. However, the proposed system will assume the following two conditions to be met:\\n1 the same position in the image coordinate system within different images corresponds to the same anatomical p</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19409</th>\n",
       "      <td>d95df0c0-456c-479f-9a64-e32e1c9f1a26</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI study and detailed protocols were described previously in Liu and colleagues [12] . Briefly, the imaging protocol included a high resolution sagittal 3-dimensional T1-weighted magnetization prepared rapid gradient echo (MPRAGE) volume and axial proton density/T2weighted fast spin echo images using 1.5-T MR systems. Image analysis uses an automated atlas based segmentation scheme developed by Fischl and colleagues [13] [14] [15] to define regional volumes and regional surface area patches. The regional volumes were normalized measures by the intracranial volume (e.g., hippocampal volume divided by intracranial volume), while the regional surface measures are characterized by average cortical thickness and were not normalized [16] . Each volume or cortical thickness measure is described by an anatomical region. Exam-ples of the regional volume measures and regional cortical thickness measures are shown in Supplementary Figure 2 . QC of the imaging data was carried out as previously described [17, 18] . We checked the imaging data for violation of any standard assumption of the statistical model (linear regression) that we used for the analysis. Appropriate transformation, e.g., log-transformation was applied where necessary to enhance symmetry. Each of the (transformed) volume</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11468</th>\n",
       "      <td>3f3033e9-4f55-4fd0-ac47-330be5a51791</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI and NACC, the duration between two assessments is strongly associated with the transition of MCI individuals back to the CN state. Although statistical significance was not shown for back-transitions from the dementia state, in all the cases, the longer the duration between two assessments, the higher the chance of individuals moving backwards from any of the disease states. This might be related to the frequency of patientclinician contact, with the chance of a misdiagnosis being increased when the patient is not assessed frequently and adequately.\\nUnique subject identifier/Roster ID (RID): In most models, a high proportion of the total variance was explained by individual patient differences. These could be unaccounted for measures such as medications, but a high intra-class correlation coefficient (ICC) also indicates that the probability of transitioning back to a less severe clinical state varies more between people, than within observations for an individual.\\nCognitive performance: The models incorporating cognitive function that was assessed by MMSE and ADAS-Cog 11 tests before back-transitions (Models 2a and 2b) suggest that the score in these tests is significantly associated with both MCICN and DCN/MCI transitions, with individuals performing better in the tests be</td>\n",
       "      <td>-4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19592</th>\n",
       "      <td>d5fdf68f-54d5-4f14-a838-bcd9474490e0</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI to identify novel loci associated with several AD p FWE-corr =Voxel-level p-value after family-wise error correction; k=number of voxels in cluster; p uncorr =Cluster-level uncorrected p-value; p corr = Cluster-level p-value after random field theory correction All voxels are significant after false discovery rate (FDR) correction (p=0.044)\\nClusters that are significant after random field theory and FDR correction (FDR q=0.067) are indicated in bold phenotypes, including: hippocampal atrophy , temporal lobe structure ), brain-wide imaging phenotypes and cerebrospinal fluid measures (Han et al., 2010; Kim et al., 2011) . To our knowledge, this report represents the first study to use PiB-PET data as a quantitative phenotype to identify genes other than APOE (Drzezga et al., 2009; Morris et al., 2010; Reiman et al., 2009 ) that are possibly associated with fibrillar amyloid burden, and hence probable AD susceptibility. 103 participants in the ADNI cohort had PiB-PET scans, and an automated ROI template extraction method was applied to sample different brain areas. The average normalized PiB uptake values from anterior cingulate, frontal cortex, parietal and precuneus regions are often used to classify individuals as having either positive or negative amyloid deposition . Becau</td>\n",
       "      <td>71</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8408</th>\n",
       "      <td>2e3db1fa-2d93-4212-aa2c-487d858054ab</td>\n",
       "      <td>1</td>\n",
       "      <td>adni|alzheimer s disease neuroimaging initiative adni</td>\n",
       "      <td>ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>ADNI. This requires that we take a two-tiered approach where more basic TF-fMRI and diffusion sequences are acquired on the lower performance systems while the most advanced possible acquisition protocols are used on high performance systems. At this point the diagnostic value of coronal highresolution T2 for hippocampal subfield analysis is still being evaluated as a potential addition to the above.\\nGiven that the primary objective of ADNI is to improve methods for clinical trials, it might at first seem out of scope to pursue advanced methods as described previously which cannot be performed at all sites. However, technical advances in MR are continuous. Methods that are advanced at the beginning of ADNI-3 (late 2016) are likely to be standard and widely available later in the ADNI-3 grant cycle.\\nOur objective is to anticipate the cycle of technical advances so that we have data demonstrating the use of advanced methods for clinical trials (or lack thereof) toward end of the ADNI-3 grant cycle when these methods should be widely available. Viewed from this perspective, incorporating methods that are considered advanced at the beginning of the ADNI-3 grant cycle fulfills the mandate of ADNI to serve the interests of AD clinical trials.\\nOur aims will include: creating standardize</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Id  is_multi  \\\n",
       "27897  50360796-e02b-49e1-8de8-4f9c01f715f2         1   \n",
       "39706  7bba3169-50ae-4ac7-9c5a-b8dba5918149         0   \n",
       "11450  3f3033e9-4f55-4fd0-ac47-330be5a51791         1   \n",
       "33971  07fde929-348c-4408-bdd7-15627aba6ae7         1   \n",
       "56198  165eaf2d-2a65-4b56-974b-6f2a9f42a390         0   \n",
       "38055  3ba42bd7-4106-4470-b606-385f12b7566d         1   \n",
       "27323  50b0c82c-2a54-40be-990c-2a6cb033ba6c         0   \n",
       "38467  b2769b41-6264-4457-acde-90aa25fea067         1   \n",
       "31267  7e875ded-00ec-4570-8c5d-c39478bdf85d         1   \n",
       "32199  54a8145c-6503-4fa7-9e77-ead6321bdf7d         1   \n",
       "47255  6fa563ab-1ced-40a3-a626-103306098092         1   \n",
       "7579   6348404c-81b2-4bb2-8a55-6a8f9880725f         1   \n",
       "28946  c3e7b7fc-ea29-43af-8559-98f323d1007d         1   \n",
       "52167  a35ecb88-abc8-4626-b411-2e70a67893b4         0   \n",
       "60944  a1d94284-c438-4d0c-a8dd-f1bf65a70291         0   \n",
       "23137  689b095a-a58a-4300-a06d-0c1f222c8a80         0   \n",
       "19409  d95df0c0-456c-479f-9a64-e32e1c9f1a26         1   \n",
       "11468  3f3033e9-4f55-4fd0-ac47-330be5a51791         1   \n",
       "19592  d5fdf68f-54d5-4f14-a838-bcd9474490e0         1   \n",
       "8408   2e3db1fa-2d93-4212-aa2c-487d858054ab         1   \n",
       "\n",
       "                                                                                                               ground_truth  \\\n",
       "27897                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "39706                                                                                                                  adni   \n",
       "11450                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "33971                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "56198                                                                                    early childhood longitudinal study   \n",
       "38055                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "27323                                                                                                                  adni   \n",
       "38467                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "31267                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "32199                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "47255  beginning postsecondary student|beginning postsecondary students|beginning postsecondary students longitudinal study   \n",
       "7579                                                                 adni|alzheimer s disease neuroimaging initiative adni    \n",
       "28946                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "52167                                                                                    early childhood longitudinal study   \n",
       "60944                                                                                          genome sequences of covid 19   \n",
       "23137                                                                                                                  adni   \n",
       "19409                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "11468                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "19592                                                                adni|alzheimer s disease neuroimaging initiative adni    \n",
       "8408                                                                 adni|alzheimer s disease neuroimaging initiative adni    \n",
       "\n",
       "                                                                                                             dataset_labels  \\\n",
       "27897                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "39706                                                                                                                  ADNI   \n",
       "11450                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "33971                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "56198                                                                                    Early Childhood Longitudinal Study   \n",
       "38055                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "27323                                                                                                                  ADNI   \n",
       "38467                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "31267                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "32199                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "47255  Beginning Postsecondary Student|Beginning Postsecondary Students|Beginning Postsecondary Students Longitudinal Study   \n",
       "7579                                                                ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "28946                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "52167                                                                                    Early Childhood Longitudinal Study   \n",
       "60944                                                                                          genome sequences of COVID-19   \n",
       "23137                                                                                                                  ADNI   \n",
       "19409                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "11468                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "19592                                                               ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "8408                                                                ADNI|Alzheimer's Disease Neuroimaging Initiative (ADNI)   \n",
       "\n",
       "       is_impossible  answer_start  answer_end  \\\n",
       "27897              0             0           4   \n",
       "39706              0             0           4   \n",
       "11450              0             0           4   \n",
       "33971              0             0           4   \n",
       "56198              0             0          34   \n",
       "38055              0             0           4   \n",
       "27323              0             0           4   \n",
       "38467              0             0           4   \n",
       "31267              0             0           4   \n",
       "32199              0             0           4   \n",
       "47255              0             0          31   \n",
       "7579               0             0           4   \n",
       "28946              0             0           4   \n",
       "52167              0             0          34   \n",
       "60944              0             0          28   \n",
       "23137              0             0           4   \n",
       "19409              0             0           4   \n",
       "11468              0             0           4   \n",
       "19592              0             0           4   \n",
       "8408               0             0           4   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       context  \\\n",
       "27897    ADNI subjects (mean ages  80 years 11 months vs. 75 years 5 months). Fourth, the ADNI MCI sample was restricted to the AD prodrome, a-MCI, and the AD sample was restricted to probable AD. The Wechsler logical memory test was used to distinguish a-MCI subjects from other MCI subjects during initial testing: Subjects were required to have scores in the 2-8 range on the delayed part of this test (the maximum score is 25) to be included in the MCI sample. As a result, although ADAMS MCIs were a mixture of a-MCI and n-MCI, ADNI MCIs were exclusively a-MCI. This is important when it comes to testing theoretical hypotheses about the retrieval processes that differentiate HC, MCI, and AD groups and that predict future HC  MCI and MCI  AD transitions. Those processes might be different when the MCI group is restricted to subjects with significant memory impairment and when the AD group is restricted to probable AD.\\nAs mentioned, ADNI subjects were rediagnosed at regular intervals over the next 2 years. Nearly half the a-MCI subjects converted to AD, and the rest did not (designated as the a-MCI C and a-MCI NC subgroups below). A small proportion (8%) of the HC subjects converted to a-MCI, and the rest did not (designated as the HC C and HC NC subgroups below). Before detailed results are    \n",
       "39706     ADNI study to ensure compatibility across scanners [28] . Full brain and skull coverage was required and detailed quality control was carried out on all MR images according to the AddNeuroMed quality control procedure [23, 29] . We applied the Freesurfer pipeline (version 4.5.0) to the MRI images to produce regional cortical thickness and subcortical volumetric measures. Cortical reconstruction and subcortical volumetric segmentation includes removal of non-brain tissue using a hybrid watershed/surface deformation procedure [30] , automated Talairach transformation, segmentation of the subcortical white matter and deep grey matter volumetric structures (including hippocampus, amygdala, caudate, putamen, ventricles) [30] [31] [32] , intensity normalization [33] , tessellation of the grey matter white matter boundary, automated topology correction [34, 35] , and surface deformation following intensity gradients to optimally place the grey/white and grey/cerebrospinal fluid borders at the location where the greatest shift in intensity defines the transition to the other tissue class [36] [37] [38] . Once the cortical models are complete, registration to a spherical atlas takes place which utilizes individual cortical folding patterns to match cortical geometry across subjects [39] .   \n",
       "11450   ADNI, and also one of the most widely used test of dementia severity in NACC [30] .\\nDepression scores (Geriatric Depression Scale, GDS): These are scores from a screening test designed to identify depression symptoms in the elderly. A 15-item GDS bigger or equal to 6 was an exclusion criterion in ADNI. Individuals with history of major depression or bipolar disorder within the past year were also excluded from the study. In NACC, GDS is not recorded for individuals with severe dementia, but it is not used as an exclusion criterion for study entry. It should be noted, however, that GDS is not a required form in NACC, so it may not be recorded for any participant at any visit. Due to the inclusion/exclusion criteria and the reduced number of assessments of the GDS score in the datasets considered, the results and conclusions about the potential effect of depression should be interpreted with extra caution. Individuals were classified in three clinical states: CN, MCI and D. We focused on MCICN, DMCI and DCN as the possible back-transitions during disease development. In ADNI, there were no direct transitions from D back to CN. In NACC, 43 such transitions were observed. The possible transitions between the different states are as shown in the schematic diagram of Fig. 1 .\\nFor the a   \n",
       "33971   ADNI.\\nLessons from ADNI relevant to the PD initiative include the need to define the key scientific questions to be answered, standardize data collection protocols, build tools that are sophisticated and matched to the data collected, maintain open communication with the research community about their needs to predict future needs; and anticipate what informatics tools/resources will be needed to address new research questions. Several platforms and networks recently established or in development are positioned to address some of these issues:\\n The MRC Dementias Platform UK (DPUK) plans to bring together 22 cohorts from across the UK, including the UK Biobank, integrated into a single informatics platform. DPUK also plans to develop a readiness cohort with baseline imaging data as well as amyloid, genetics discovery, and -omics discovery cohorts. (EMIF) is a five-year IMI with 56 partners in 14 European countries, established to make datasets visible to researchers, to integrate research cohorts for combined analysis, and to enable re-use of medical and other data for research. IMI-EMIF is establishing three broad approaches to data reutilizing and sharing. Firstly, to make data visible and potentially utilizable by researchers, it has established a browser for meta-data or descr   \n",
       "56198     Early Childhood Longitudinal Study in the U.S. found that children who were overweight when they entered kindergarten were 4 times more likely to be obese at age 14 than children who entered kindergarten at a healthy weight. 16 Once present, obesity is difficult to treat due to metabolic changes that resist weight loss. 17 Effective primary prevention efforts are needed early in life before physiologic barriers to weight loss take hold and less healthful weight-related behaviours become entrenched. The current study examines the efficacy of a primary obesity prevention intervention that embeds weight-related messages within a parenting program that has been shown to improve parenting behaviors among racial/ethnic minority families. 18 A formative pre-post uncontrolled trial with 16 families showed that we could feasibly implement the Parents and Tots Together intervention within a community setting and the intervention was acceptable to families. 6 The purpose of the current study was to assess the extent to which the Parents and Tots Together intervention, compared with controls who received weekly mailings, resulted in a smaller increase in BMI (primary outcome) and improvements in children's weight-related behaviors and parental feeding and general parenting behaviors among ra   \n",
       "38055                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               ADNI data set to support currently hypothetical models, but further to highlight uncertainty in those orderings and variation among different subgroups. We also demonstrate that such a model can provide a practical and effective staging system for patient prognosis.   \n",
       "27323    ADNI was not designed to investigate the relationship between vascular disease and risk factors and cognitive decline, the variables making up the Vascular Index score were recorded as dichotomous values (present/ absent) and severity, duration, and timing of vascular risk factors were not accounted for. Therefore, there may have been underreporting or nonspecific reporting of vascular risk factors, which may have led to an underestimation of the effects of vascular risk factors on cognitive decline. The sample predominantly consisted of subjects with MCI, and therefore it is possible that this diagnostic group drove the results. However, the various models included interaction terms of vascular disease and risk factors with diagnostic group and those were not significant suggesting that diagnostic group did not modify the relationship between vascular disease and risk factors and cognitive impairment. Finally, due to our large sample, certain statistically significant results were not necessarily clinically relevant. Therefore, various designations of effect size were provided to better interpret the results.\\nIn conclusion, these results suggest that there is a significant association between increased vascular disease and risk factors and cognitive impairment in the AD spectrum   \n",
       "38467     ADNI2/GO dataset (using T1w and FLAIR scans). Not using the T2w/PD information did not change the performance of the Random Forest classifier (SI=0.66  0.17, ICC=0.99). However, not using FLAIR information in the ADC dataset significantly decreased the Dice Kappa, but the volumetric correlation did not drastically change (SI=0.47  0.21, ICC=0.95). White matter hyperintensities (WMHs), commonly identified as areas of increased signal in relation with the surrounding white matter regions on T2w, PD and FLAIR MRIs, are one of the non-specific yet typical and constant MRI expressions of cerebral small vessel disease (CSVD), along with lacunar infarcts and microhemorrhages (Conklin et al., 2014; Gouw et al., 2010) . They have been shown to be more extensive in patients with Alzheimer's disease compared to agematched healthy normal populations (Yoshita et al., 2005) . WMHs reflect ischemic injury in the elderly and AD populations and the existence and severity of WMHs can lead to or accelerate decline in cognitive as well as executive functions (Dubois et al., 2014) . As a result, the location and load of WMHs are important clinical measures, raising substantial need for their accurate quantifications. WMHs are generally detected using fluid attenuated inversion recovery (FLAIR) or T2w   \n",
       "31267    ADNI1, ADNIGO, ADNI2, and AIBL datasets were downloaded from Alzheimer's disease Neuroimaging Initiative (ADNI) database (http://adni.loni.usc.edu/). The Australian Imaging, Biomarker & Lifestyle (AIBL) Flagship Study of Ageing is a collaborative study that shares many common goals with ADNI (http://adni.loni.usc.edu/study-design/collaborative-studies/ aibl/). Only ADNI-compliant subjects with at least three timepoints from AIBL were included in this study. For all ADNI cohorts, subjects with clinical assessments from at least three visits, in timespan longer than one year, were included in the analysis. Subjects were further excluded based on manual quality checks after MR preprocessing pipelines (described below). Age, Apolipoprotein E4 (APOE4) status, clinical scores from mini-mental state exam (MMSE) and Alzheimer's Disease Assessment Scale (ADAS-13), and T1-weighted MR images were used in the analysis. Subject demographics are shown in Table 1 , and the complete list of included subjects is provided in S1 File.\\nThe ADNI sample comprising pooled ADNI1, ADNIGO, and ADNI2 subjects was used to perform primary analysis comprising trajectory modeling and prediction tasks, whereas AIBL subjects were used as the independent replication cohort for the prediction task. There are a few   \n",
       "32199     ADNI were found to meet the above criteria and are thus included in the P-MCI group. For the other three clinical groups, subjects are selected to match the demographic information in the P-MCI group and to have the same gender and age. Specifically, for each subject in P-MCI group, a subject with the same gender and age is sought in the other group. If this is not possible, the gender constraint is relaxed first, and then the age constraint. However, under no circumstances are subjects with an age difference greater than 3 years included. Due to the similar reason for the calculation of dynamic features, the subjects in the other clinical groups are required to have at least 4 time-points. The demographic and clinical information of all the selected subjects in the four groups are summarized in Table 1 . The preprocessing step performed in our method is a standard procedure as used in general brain image analysis, aiming to reduce image noise and remove non-brain tissues. For each image, intensity inhomogeneity is firstly corrected using the N3 algorithm (Sled et al., 1998) . Many algorithms have been developed to remove non-brain tissues, such as the skull and the extra-cranial tissues, including Brain Surface Extractor (BSE) (Shattuck and Leahy, 2001 ) and Brain Extraction Too   \n",
       "47255     Beginning Postsecondary Students: Two Years Later (Washington, D.C.:1994). Appendix A contains a detailed description of the persistence and attainment variables used in this report. degree, or a vocational certificate. This perspective is useful when the level of the degree that the students are seeking is not the highest undergraduate degree offered at the institution that they are attending at the time. This is especially common at community colleges, where students May be taking courses toward either a bachelor's degree or a vocational certificate rather than an associate's degree. The fourth approach presented in this essay is to focus specifically on the students with a bachelor's degree objective who are beginning at 4-year institutions and to trace their progress towards the bachelor's degree on a year-by-year basis. This perspective is useful in determining what proportion of beginning students at 4-year colleges follow a path of continuous enrollment towards the bachelor's degree and how long it takes them to achieve their objective. One of the most important distinctions in studying persistence and attainment is the highest undergraduate degree offered at the institution in which the student enrolls, because the time spent at the institution reflects the normal duratio   \n",
       "7579    ADNI-GO and ADNI-2 will follow 3 cohorts of subjects.\\n(1) Cognitively normal and late MCI subjects carried forward from ADNI-1 (followed at 1.5T); (2) early MCI enrolled in GO and carried forward into ADNI-2 (scanned at 3T); and (3) cognitively normal, late MCI, and Alzheimer's disease (AD) subjects newly enrolled in ADNI-2 (scanned at 3T).\\nNext, we describe the rationale that led to the selection of the MRI protocol for ADNI-GO and ADNI-2. Our approach to the ADNI-GO and ADNI-2 MRI protocol will be to maintain MRI methodological consistency to the greatest extent possible in previously enrolled ADNI-1 subjects, and to maximize the value of the longitudinal MRI data in these subjects. However, for newly enrolled subjects in GO (and ADNI-2 if funded), we will modernize and expand the MRI protocol to remain technically current, within the constraints imposed by having to operate in a reasonably consistent manner across many individual scanner models representing the three largest MRI vendors. Given the sensitivity of MRI as a biological marker demonstrated in ADNI-1, ADNI-GO and ADNI-2 are designed to further assess usefulness among individuals who are cognitively normal or have even more subtle cognitive impairment. This approach will serve to address two important objectives: how   \n",
       "28946    ADNI) database (www.loni.ucla.edu/ADNI). The ADNI was launched in 2003 by the National Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration (FDA), private pharmaceutical companies and non-profit organizations, as a $60 million, 5-year public-private partnership. The primary goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). Determination of sensitive and specific markers of very early AD progression is intended to aid researchers and clinicians to develop new treatments and monitor their effectiveness, as well as lessen the time and cost of clinical trials.\\nThe Principle Investigator of this initiative is Michael W. Weiner, M.D., VA Medical Center and University of California, San Francisco. ADNI is the result of efforts of many coinvestigators from a broad range of academic institutions and private corporations, and subjects have been recruited from over 50 sites across the U.S. and Canada. The initial goal of ADNI was to recruit 800 adults, ages 55 to 90   \n",
       "52167     Early Childhood Longitudinal Study project (ECLS) provides decisionmakers, researchers, child care providers, teachers, and parents with detailed information about children's early life experiences through two cohorts, the Birth Cohort (ECLS-B) and the Kindergarten Cohort (ECLS-K). The ECLS-B, the focus of this report, is a large scale nationally representative probability sample of children born in 2001 selected from a multistage sample design. The sample size for the base year data collection, which occurred when children were approximately 9 months of age, was 13,921. The overall response rate (10,688 parent completes) was 74.1 percent. Details on the sample design, sample selection, and data collection can be found in the ECLS-B Methodology Report for the Nine-Month Data Collection, Volume 2: Sampling (NCES 2005-113), available from NCES at http://nces.ed.gov/ecls.  The ECLS-B is a rich data set that obtains information about a broad range of children's early experiences. Data collection is intended to continue through the end of first grade with the subsequent data collections at 2 years, 4 years, kindergarten, and the final data collection during first grade. This report documents the methodology for the child assessments in the ECLS-B, including the design, construction, i   \n",
       "60944    genome sequences of COVID-19 and of Ebola [26] .\\nInterestingly, a study of isolated phospholipid monolayers [27] without any viral environment and with various degrees of unsaturation has shown similar kinetic behavior to that for SARS. The degradation with time of different phospholipid molecules exposed to laboratory air was monitored. Remembering the discussion above about the effect of the proximity of double bonds in the lipid structure to the sites for hydrogen atom removal, it is interesting to see that a lipid with one double bond had a longer degradation t 1/2 of 6120 s than the t 1/2 of 5040 s for a lipid with two double bonds. Some caution is needed, though, in making comparisons of t 1/2 values. For example, the phospholipids were, as mentioned, exposed to laboratory air and hence to ambient lighting conditions, and, as we have already indicated and as we shall see further below, light can enhance the reaction kinetics. Then, as will also be discussed below, rates of lipid oxidation can vary depending on their physical state. For the phospholipid studies, monolayers were spread on a pure water surface of a Langmuir trough. Surface oxidations are generally slower than for aerosol samples so that may be why the rates of oxidation of simple molecules appear to be less ra   \n",
       "23137   ADNI participants, acquired from Siemens, general electric (GE), Philips, Siemens HRRT and BioGraph HiRez PET scanners, were collected from the ADNI Laboratory on NeuroImaging (LONI, University of California, Los Angeles) website (http://www.loni.ucla.edu/ADNI/). Participant's enrolment was conditioned to some eligibility criteria. General inclusion/exclusion criteria were as follows:\\n Normal control subjects: MMSE scores between 24 and 30 (inclusive), a CDR of 0, non-depressed, nonMCI, and nondemented. The age range of normal subjects will be roughly matched to that of MCI and AD subjects. For posterior analysis, the data was arranged into only one group, considering the case AD vs CTRL. This group has n = 196 images in total: 101 CTRL and 95 AD. We will consider that each spatially and intensity normalized image from the database corresponds to a different observation of the brain. The complexity of brain structures and the differences between brains of different subjects makes difficult to use the registered images for all type of calculations that directly compares them with each other. However, the proposed system will assume the following two conditions to be met:\\n1 the same position in the image coordinate system within different images corresponds to the same anatomical p   \n",
       "19409     ADNI study and detailed protocols were described previously in Liu and colleagues [12] . Briefly, the imaging protocol included a high resolution sagittal 3-dimensional T1-weighted magnetization prepared rapid gradient echo (MPRAGE) volume and axial proton density/T2weighted fast spin echo images using 1.5-T MR systems. Image analysis uses an automated atlas based segmentation scheme developed by Fischl and colleagues [13] [14] [15] to define regional volumes and regional surface area patches. The regional volumes were normalized measures by the intracranial volume (e.g., hippocampal volume divided by intracranial volume), while the regional surface measures are characterized by average cortical thickness and were not normalized [16] . Each volume or cortical thickness measure is described by an anatomical region. Exam-ples of the regional volume measures and regional cortical thickness measures are shown in Supplementary Figure 2 . QC of the imaging data was carried out as previously described [17, 18] . We checked the imaging data for violation of any standard assumption of the statistical model (linear regression) that we used for the analysis. Appropriate transformation, e.g., log-transformation was applied where necessary to enhance symmetry. Each of the (transformed) volume   \n",
       "11468   ADNI and NACC, the duration between two assessments is strongly associated with the transition of MCI individuals back to the CN state. Although statistical significance was not shown for back-transitions from the dementia state, in all the cases, the longer the duration between two assessments, the higher the chance of individuals moving backwards from any of the disease states. This might be related to the frequency of patientclinician contact, with the chance of a misdiagnosis being increased when the patient is not assessed frequently and adequately.\\nUnique subject identifier/Roster ID (RID): In most models, a high proportion of the total variance was explained by individual patient differences. These could be unaccounted for measures such as medications, but a high intra-class correlation coefficient (ICC) also indicates that the probability of transitioning back to a less severe clinical state varies more between people, than within observations for an individual.\\nCognitive performance: The models incorporating cognitive function that was assessed by MMSE and ADAS-Cog 11 tests before back-transitions (Models 2a and 2b) suggest that the score in these tests is significantly associated with both MCICN and DCN/MCI transitions, with individuals performing better in the tests be   \n",
       "19592    ADNI to identify novel loci associated with several AD p FWE-corr =Voxel-level p-value after family-wise error correction; k=number of voxels in cluster; p uncorr =Cluster-level uncorrected p-value; p corr = Cluster-level p-value after random field theory correction All voxels are significant after false discovery rate (FDR) correction (p=0.044)\\nClusters that are significant after random field theory and FDR correction (FDR q=0.067) are indicated in bold phenotypes, including: hippocampal atrophy , temporal lobe structure ), brain-wide imaging phenotypes and cerebrospinal fluid measures (Han et al., 2010; Kim et al., 2011) . To our knowledge, this report represents the first study to use PiB-PET data as a quantitative phenotype to identify genes other than APOE (Drzezga et al., 2009; Morris et al., 2010; Reiman et al., 2009 ) that are possibly associated with fibrillar amyloid burden, and hence probable AD susceptibility. 103 participants in the ADNI cohort had PiB-PET scans, and an automated ROI template extraction method was applied to sample different brain areas. The average normalized PiB uptake values from anterior cingulate, frontal cortex, parietal and precuneus regions are often used to classify individuals as having either positive or negative amyloid deposition . Becau   \n",
       "8408   ADNI. This requires that we take a two-tiered approach where more basic TF-fMRI and diffusion sequences are acquired on the lower performance systems while the most advanced possible acquisition protocols are used on high performance systems. At this point the diagnostic value of coronal highresolution T2 for hippocampal subfield analysis is still being evaluated as a potential addition to the above.\\nGiven that the primary objective of ADNI is to improve methods for clinical trials, it might at first seem out of scope to pursue advanced methods as described previously which cannot be performed at all sites. However, technical advances in MR are continuous. Methods that are advanced at the beginning of ADNI-3 (late 2016) are likely to be standard and widely available later in the ADNI-3 grant cycle.\\nOur objective is to anticipate the cycle of technical advances so that we have data demonstrating the use of advanced methods for clinical trials (or lack thereof) toward end of the ADNI-3 grant cycle when these methods should be widely available. Viewed from this perspective, incorporating methods that are considered advanced at the beginning of the ADNI-3 grant cycle fulfills the mandate of ADNI to serve the interests of AD clinical trials.\\nOur aims will include: creating standardize   \n",
       "\n",
       "       context_token_length  \n",
       "27897                    55  \n",
       "39706                    28  \n",
       "11450                    25  \n",
       "33971                    12  \n",
       "56198                   -14  \n",
       "38055                    49  \n",
       "27323                   -31  \n",
       "38467                    65  \n",
       "31267                    64  \n",
       "32199                    20  \n",
       "47255                   -13  \n",
       "7579                     43  \n",
       "28946                    27  \n",
       "52167                    31  \n",
       "60944                    33  \n",
       "23137                    22  \n",
       "19409                    12  \n",
       "11468                    -4  \n",
       "19592                    71  \n",
       "8408                      4  "
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.sample(20).head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "11987bd9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1    0.663519\n",
       "0    0.336481\n",
       "Name: is_multi, dtype: float64"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"is_multi\"].value_counts(normalize=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "4df556a1",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_parquet(\"output/train.parquet\", index=False)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
